Giorgio Carta

Giorgio Carta

Data Analyst - Bionformatics at NIBRT

Location
Ireland
Industry
Pharmaceuticals

As a LinkedIn member, you'll join 135 million other professionals who are sharing connections, ideas, and opportunities. And it's free! You'll also be able to:

  • See who you and Giorgio Carta know in common
  • Get introduced to Giorgio Carta
  • Contact Giorgio Carta directly

View Full Profile

Giorgio Carta's Overview

Current
  • Data Analyst - Bionformatics at NIBRT
Past
  • Co-founder at Compchem.ie
  • Founder at CodeX discovery
  • Post Doctoral Research Fellow at Trinity College Dublin
Education
  • Trinity College, Dublin
  • Università degli Studi di Cagliari
  • Università degli Studi di Cagliari
Recommendations

3 people have recommended Giorgio

Connections

127 connections

Websites

Giorgio Carta's Summary

Computational Chemist and Application developer with extensive experience using standard molecular modeling computational software packages (Pipeline Pilot, MOE, Openeye package etc.) applied to ligand and structure based design and other CADD techniques.
My goaI as a scientist is to progress my career as part of a pharmaceutical R&D department.

Specialties

Coding experience using various scripting languages (Python, PERL, PilotScript, SVL, R, SQL, PHP) which I use for the development of novel CADD applications. Weblab integration and solutions (lims systems)

Giorgio Carta's Experience

Data Analyst - Bionformatics

NIBRT

Nonprofit; 51-200 employees; Biotechnology industry

July 2011Present (7 months) Dublin

Developing of web applications for the systematic collection of carbohydrate structures and their experimental data.

Co-founder

Compchem.ie

January 2011July 2011 (7 months)

Computational Chemistry Ireland is a not-for-profit networking organization for computational chemists in Ireland. The aim is to encourage and develop a computational chemistry community across Ireland.

Founder

CodeX discovery

December 2009July 2011 (1 year 8 months)

Co-founder of Codex Discovery and Codex Oncology Ltd. CodeX is an early-phase therapeutic development company employing rational drug discovery approaches to deliver tomorrow's new medicines.

Post Doctoral Research Fellow

Trinity College Dublin

Educational Institution; 1001-5000 employees; Higher Education industry

January 2009July 2011 (2 years 7 months)

Project Manager - Responsible for the optimization of novel agents for the therapy of Parkinson's disease, to deliver pharmaceuticals with enhanced brain permeability to maximize selectivity and efficacy.
I am part of a team dedicated developing a web based tiered screening platform for drug discovery.

Postdoctoral Research Fellow

Trinity College Dublin

Educational Institution; 1001-5000 employees; Higher Education industry

January 2008January 2009 (1 year 1 month)

Through the interaction with pharmaceutical consultants I collaborated to the progression and the pre-clinical optimization of anti-cancer agents (MPM, NSCLC) and co-applied to the SDD Wellcome Trust for additional funding.
I performed lead optimization of novel series of GR modulator, with the main goal of increasing the biological activity and their application in Major Depression disorder and inflammatory diseases.

Giorgio Carta's Languages

  • English

    (Professional working proficiency)
  • Italian

    (Native or bilingual proficiency)

Giorgio Carta's Education

Trinity College, Dublin

PhD, Computational Chemistry

20042007

Activities and Societies: Identification a novel agonist for the PPARγ receptor and a Structural Activity Relationship (SAR) for a class of novel modulators.

Università degli Studi di Cagliari

MSc, Pharmaceutical Chemistry

20002002

Università degli Studi di Cagliari

BSc, Chemistry and Pharmaceutical Technologies (CTF)

19962000

Activities and Societies: Faculty of Pharmacy

Giorgio Carta's Additional Information

Websites:
Interests:

new technologies, photography, web-devolpment

Groups and Associations:

compchem.ie

Honors and Awards:

2011 ICHEC Class B: PPARγ Tiered Virtual ScreeningDevelopment of an Improved
PostHit Scoring Processwork-flows. (Value €14,000)
2010 ICHEC Class C: The use of Document Oriented Database to support "High
Throughput Virtual Screening (HTVS)" work-flows. (Value €600)
2009 Enterprise Ireland: Proof of Concept for the optimization of novel
PPAR-gamma Modulator (€100,000).
2008 Wellcome Trust, Seeding Drug Discovery, 2008-10;Optimisation of inhibitors
of XIAP for treatment of Mesothelioma (Value £30,000).

Contact Giorgio for:

  • career opportunities
  • consulting offers
  • new ventures
  • job inquiries
  • expertise requests
  • business deals
  • reference requests
  • getting back in touch

View Giorgio Carta’s full profile to...

  • See who you and Giorgio Carta know in common
  • Get introduced to Giorgio Carta
  • Contact Giorgio Carta directly

View Full Profile

Viewers of this profile also viewed...